Enhanced Pharmacological Ascorbate Oxidation Radiosensitizes Pancreatic Cancer

Authors:

Abstract
Pharmacologic ascorbate (P-AscH–) is emerging as a promising adjuvant for advanced pancreatic cancer. P-AscH– generates hydrogen peroxide (H2O2), leading to selective cancer cell cytotoxicity. Catalytic manganoporphyrins, such as MnT4MPyP, can increase the rate of oxidation of P-AscH–, thereby increasing the flux of H2O2, resulting in increased cytotoxicity. We hypothesized that a multimodal treatment approach, utilizing a combination of P-AscH–, ionizing radiation and MnT4MPyP, would result in significant flux of H2O2 and pancreatic cancer cytotoxicity. P-AscH– with MnT4MPyP increased the rate of oxidation of P-AscH– and produced radiosensitization in all pancreatic cancer cell lines tested. Three-dimensional (3D) cell cultures demonstrated resistance to P-AscH–, radiation or MnT4MPyP treatments alone; however, combined treatment with P-AscH– and MnT4MPyP resulted in the inhibition of tumor growth, particularly when also combined with radiation. In vivo experiments using a murine model demonstrated an in...

This publication has 36 references indexed in Scilit: